“Our strategy is to achieve double digit growth by being the ‘go to’ European specialist pharma company partner of choice. We are committed to the development of innovative products and are seeking to acquire late stage assets.

Our three key strategic priorities are: to achieve double digit growth, to strengthen our late stage pipeline and to be a dynamic place to work.”

Peter Stein
CEO, Norgine



Strategic priorities and business model

Achieve double digit growth


Maintain a strong late stage pipeline


Be a dynamic place to work


Business model


Collaborating with partners who share our vision for improving healthcare

Partner for a healthy life